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The synthesis of the four L-pentapeptides containing the Ala. 
Glu. Lys. Ala. Ala. sequence, which differ with regard to the 'sHe 
of linkage between the glutamyl-lysyl residues, is described. 
In each case the chain was built by coupHng the protected N-
-termi:nal dipeptide N-hydroxysuccinimide esiter (II or IV) with 
the C-terminal tripeptide benzyl ester (VIII or X). The sequen-
tially .identical L-D-L-D-D-pentapeptide having the y-carboxy-group 
of D-glutamic acid residue involved in the .peptide ·bond, was pre-
pared after the same general pattern. Complete deprotection of the 
isomers i111 two successive steps gave the free pentapeptides which 
were characterized as solid di-trifluoroacetate salts by analytical, 
optical and proton NMR spectral data. The isomers were compared 
by paper electrophoresis at different pH values. The alantne methyl 
resonances in the NMR spectra of the a-a L-pentapeptide XVIII 
and the y-a L-D-L-D-D-pentapeptide XXII were assigned by ob-
serving the shift in spectral lines with varying pH. 
INTRODUCTION 
Ln a previous :paper1 from this laboratory it was reported that the incub-
ation of the bir01Jin-requiiring mutant of Brevibacterium divaricatum wiith 
penicillin, or semisym:thetk penicillrns, led to the accumulafaon of soluble un-
crns1s-li11ked pepti!do;glycan f.ragments in the culture medium. Sho,rtly the,reafiter 
the same phenomen wa•s claiimed2,3 to 'Occur in the penicilliin-.treated cultures of 
two oither bacte11ial species. In co'Illnection with our studies on the structure 
and properties of the excreted fragments, we became linterested in model com-
pounds related to the peptide part of peptidoglycan. Synthetic work iin this 
field has been very intensive in last years, and various peptides possessing 
unusual structural and stereochemical features encountered in the bacterial 
cell-wall peptido.glycans were prepared\ mainly to elucidate the structure of 
naturally occurring material. However, fm- some of those compounds only a 
limi.ted amount of iinfo11mat~on concerning their physical data and chemical 
behaviour is available. 
* Taken in part f.rom the Ph. D. Thesis of D. G., University of Zagreb, 1974. 
** To whom the correspondence should be addressed. 
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Since we were 1particularly .~nterested in the differentiation of physical data 
due to variati:ons Ln the type of linkage between the isomers possessing the 
amino add ,sequence of the peptide moiety precursor of the cell-wall peptido-
glycan, we fkst undertook the synthesis of the penta·peptide isomers conta-
ining the L-Ala. L-Glu. L-Lys. L-Ala. L-Ala. sequence. In the present paper 
the synthesis of four structural isomers which differ wilth .regard to the 
sHe of linkage between the glutamyl-lysyl residues, is described. The sequenti-
ally identical L-alanyl-n-y-glutaml-L-lysyl-n-alanyl-n-.alanine5,6 which is 
structurally and stereoohemically .rela1ted tn the peptide units of .some 
UJncross-linked peptidoglycan chains was also prepared and folly cha,racterized. 
We now report on the synthesis and correlation of some physical data of 
the above isomeric structures. 
RESULTS AND DISCUSSION 
'Dhe general design for the synthesis of the four fully protected isomeric 
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built by coupling the protected N-terminal dipeptide N-hydroxysuocinimide 
ester (II or IV) with the C-termional tripeptide benzyl ester (VIII or X); tert-
-butoxycarbonyl (BOC) protection was used for the amino group of N-terrninal 
alanine, benzyloxycarbonyl protechon for the lysine amino function not 
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involved in the peptide bond, and benzyl groups were used to priote,ct the 
carboxy-group of C-terminal alanine and the 1- or 5-carboxy-,group of •glu-
tamic 1ac.id. The synthesis of the sequentially :identica-1 L-D-L-D-D-pentapeptide 
XVII havinig the y-carboxy-gmoup of n-glutamic acid engaged in the peptide 
bond, was patterned after that .of its stereoi'.someride XIV; it i:nV'Olved the 
coupLing of the N-termi:nal L-o-dipeptide active ester VI with the C-termi.nal 
L-D-o-tripeptide benzyl ester XII. 
The isomeric d i.peptides BOC-Ala-Glu(OBZL)-OH (I) and iEOC-Ala-
-Glu(OH)-OBZL (III) were obtained by coupling N-tert-butoxycarbonyl-L-ala-
nine N-hydroxysuccinimide ester with 5-and 1-benzyl L-glutamic acid ester, 
respectively; the products were characterized as crystalline dicyclohexyl-
amine salts. Standard treiatment of I and III with N-hydroxysucc-inimide 
afforded the corirespondinig active esters II and IV. Amal1ogously to IV, but 
using 1-benzyl o-glutamic add ester, the pmtected L-n-di:peptide active ester 
VF was obtained ·in crystalline foran and fully characterized. 
Comparison .of the NMR spectra in CDC13 of the above <isomers irevealed 
differences in the chemical shift value for the benzyl methylene protons. In 
the .spectrum of the active ester II, having the glutamate benzyl ester group 
in y-relaUonshilp to the peptide bond, the PhCH2 s1nglet {r 4.91) appeared 
at a higher field than •those of .i•someric 1-benzyl active esters IV and VI 
(r 4.87 aind 4.85). Es1sentially the same chemical .shift differene~ was 1observed 
between the 5-benzyl monoester derivative I and 1-benzyl monoester deriva-
tive V. In the spectrum of an artificial 1 : 2.5 mixture of II and JV, the 
benzyl methylene protons appeared as two well •resolved si!filglets of .appropriate 
relative •hlltensities with chemical shift difference ·of 3.5 Hz, thus indicaiting 
that the observed difference may be of diagnostic use in peptide synthesis 
involving benzyl glutamate derivatives. 
The C-terminal components VII and IX were obta-ined by coupHng the 
p-nitrophenyl esters of N2-tert-butoxycarbonyl-N6-benzyloxycarhonyl-L-lysine 
and N2-benzyloxycarbonyl-N6-tert-butoxycwb01I1yl-L-lysine, .respectively with 
L-alanyl-L-alanLne benzyl ester. In our preliminary experiments, a str.oog depen-
dence of the :reactiv.ity of p-nitrophenyl esters .on the nature of solvents8 was 
observed: with ethyl acetate as the solvent both Teaotions practicaHy 
failed whereas in dimethylformamide (DMF) the c-O'up1ing proceeded 1at ·a 
moderate rate. However, in the presence of two equivalents of imidazole the 
reaction rates .increased singnificantly, and hiigh yields (> 70°/0>) of VII and 
IX were obtained Tegardless of the solvent used. The imidazole..;promoted 
synthesis of N2-tert-butoxycarbonyl-L-lysyl-o-alanyl-n~alan~ne benzyl ester9, 10 
(XI) was perf0irmed analogously to that of VII by 1m'1ing o-Ala-o-Ala-OBZL 
as the c~terminal component. 
The NMR 1spect11um •of XI (i:n CDC13 ) revealed, in addition to the two sharp 
singlets due to the aromatic pr.otons (r 2.73) and the Me3C group (r 8.61), two 
well separated 2H + 2H singlets (r 4.88 and 4.95). On the basis of comparison 
with the spectra of related compounds, the signal at lower field was assigned 
to the PhCH2 protons of n-alanine benzyl ester group and that at a higher 
field to ithe PhCH2 pmtons of the L-lysine N6-benzyloxyc·arbooyl group. Assigne-
ment -0f the alantne methyl resonances proved to be difficult because of the 
overlapping Me3C signal. However, after the BOC deprotec1Ji1on of XI, the NMR 
spectrum of N6-benzyloxycarbonyl-L-lysyl-o-alanyl-o-alanine .benzyl ester (XII) 
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in CD30D ,revealed the alanine methyl groups as two sets of overlapped doublets 
at r 8.61 and 8.73 w.iJth the coupling constants J = 7 Hz. Acoordiing t:o the 
observatiron11 that the benzyl ester arnma:tic ring causes an upfield shift of 
the adjacent alanine methyl group, as well as on the basis of comparison of 
the alanine methyl resonances in Z-Ala-Afa-OMe (r 8.68 and 8.61, CD30D 
solution) with those .iJn Z-Ala-Ala-OBZL (r 8.68 and 8.75), the upfield doublet 
in the NMR spectrum of XII is assigned to the C-ter.minal n-alanine methyl 
group. 
Removal of the BOC protectiion from the a-amino f.unct]on of lysine 
in tripeptides VII and XI and from the E-amino func·tion in IX, gave the 
crystalline trifluo,roacetate salts of VIII, XII and X, ;respectively, which were 
charactemzed by elemental analysis and optical rotation data. 
The coupling of the dipeptide active ester II with the triipeptide components 
VIII or X led to the fuJ:ly protected a- a and a--E pentapeptides XIII and XV, 
whereas ooupli!ng of the diipeptide active esier IV with VIII or X led to ·the 
y-a and y- E rpentapeptides XIV and XVI, respectively. AHer the same 
pattern the protected y-a L-D-L-D-D-pentapeptide XVII10 was prepared from 
VI and XII. The isomeric structures having the a-amiilno group of lysine 
1nvolved 1in the :peptide bond (compounds XIII, XIV and XVII) were formed 
in higher yields th;f{n those having the E-amino function of lysine engaged in 
the peptide lillkage. 
The aompaniison of the NMR speatra of XIII-XVII in CDC13 and CD30D 
solutionis, revealed sOlffie structural differences among the 1iisomers. In CDC13, 
the methylene benzyl protons of the benzy1oxycarbonyl group aind two benzyl 
ester groups appeared as 2 singlets resonating between r 5.03-4.92 and 
r 4.88-4.84; the ratio of the upfield fo downfield signal in the spectra of the 
a-a isomer XIII and the a-E isomer XV was 2 : 1, whereas .the .reverse was 
true for the y-a Jsome:rs XIV and XVII and the y-E iisomer XVI. Hence, 
the signals of the PhCH2 protons of benzyloxycarbonyl and gl•utama<te 5-benzyl 
ester g.roup coincide at higher field and those of the PhCH2 protons of 
C-termrnal alanine and glutamate 1-'benzyl ester groups at lower field. In 
CD30D, a comparable and even more distinct picture of the PhCH2 signals 
was displayed by the isomeric structures XIV, XVI and XVII, whereas the 
spectra of the a-a Jsomer XIII and the a-E is.omer XV revealed the PhCH2 
protons as 3 resolved singlets of equal intensities. The arromatic 1protons of 
the PhCH2 gmups appeared in all cases mainly as a si1ngle peak, except .iin 
the CDC13 spectrum of the a-a isomer XIII in which the protons •Of 2· phenyl 
groups (attributed to the benzyloxycarbonyl and glutamate 5-benzyl este.r 
gnoU1p) were shifted to higher fields rela1tive to theiir :position ·iln •the spectra 
of other isomers. Due to extensive overlapping of the Me3C signal, the alamine 
methyl doublets were partly observable only when CD3 0D was used as the 
solvent; srligiht differences in chemical shifts of the methyl doublets could be 
noted when comparing the spectra of the i,somers. 
Deprotection of XIII-XVII was performed in two successive steps: the 
benzyloxycarbonyl group and the benzyl ester gToups were removed by cata-
lytic hydrogenatilO!n and the BOC group on exposure to t:dfluoroacetic acid. 
The free pentape;ptides XVIII-XXII wecr-e isolated as ·solid di-trifluo.roacetate 
salts and characterized. When kept under anhydrous condihons the iproducts 
proved to be quite stable for more than six months, however, in aqueous 
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solutions, decompositinn of the L-y-a isomer XIX and the a-£ isomer XX 
was notable after few days. On paper chromatography in 3 difforent solvent 
systems, the 'i:somers travelled mme or less parallel to each other, the diffe-
rences in mobiHty being mostly apparent in solvent system E (see Experimental 
part). 
As expected, a better resolution 'Of the isomers was achieved by paper 
electmphoresis (Table I), due to differences in p.K values between the a- and 
y-carboxy-group .of glutamic acid and the a- and i;-amino £unctfon of lys,i:ne. 
TABLE I 
ELectrophoretic mobiHties of isomeric L-pentapeptides at different pH vaiues* 
Isomer Glu, Lys 
Migration distances in cm 
No. type of 
I 
I I linkage pH 2.4 I pH 4.2 I pH 8.5 pH 11.7 
XVIII I a-a -7.1 -1.0 +o.5 I +2.0 
XIX y-a -6.1 -0.5 +o.7 +2.1 
xx a-£ -7.0 -1.0 +3.2 +3.5 
XX! y-£ -5.8 
I 
0 +3.5 +3.5 
I 
• Low voltage paper electrophoresis, 12 V/cm. Conditions : 0.2 M acetic acid, pH 2.4, 2 hr; pyri-
dine-acetic acid-water pH 4.2, 3 hr; 0.05 M sodium borate - 0.2 M boric acid buffer, 3 hr ; 0.05 M 
sodium borate - 0.2 M sodium hydroxide buffer, pH 11.7, 3 hr. Colour reaction: ninhydrin. 
At pH 2.4, the a-a and a-£ isomers XVIII and XX, having the y-carboxy-
-graup of glutamic acid ,residue free, are stro1nger ca·Hons than the isomers 
XIX and XXI im. which the acid strength of the free a-carboxy-group of 
glutamic acid residue is increased by the adjacent peptide ibo!frd12 • The slower 
mig,rabon 'Of the y-£ isomer XXI as compared to that of the y-a is·omer 
XIX can be ascribed to the acidifying effect ·Of the peptide tbond on the 
u-NH/ group of the lysine residue; the effect is less pronounced for the 
E-NH/ group i:n XIX because of the di1stance of the CONH group. A similar 
picture ·of migration rates was observed at pH 4.2, where 1the y-a and y-£ 
isomers XIX and XXI appear to be very near their isoelectric poilnts. At pH 
8.5, the influence of the lysine amino functions is predomirni:n1t: rthe a-a 
and y-a isomers XVIII and XIX containing the still ionized i;-amino group 
of lysilne are considerably less anionic than XX and XXI iin which the lysine 
a-ami:nio fonction has already lost its proton. Slight differences between the 
a-a and y-a 1eomers XVIII and XIX, as well as between the a-£ and y-< 
isomers XX and XXI can be again ascribed to the relative proximi:ties of the 
acidifying peptide bonds. In strongly basic media where all the four isomers 
behave as true anionic species, the difference in migration between the a-
and i;-ly,syl bonded isomers is much les·s pr:ono1unced. 
The NMR spectra at 60 MHz of D20 •solutions of the pentapeptides 
XVIII-XXII di-trifluoroaceta:te salts revealed cocns,iderable resemblance. The 
most notable differences in resonance :positions of the alanine methyl 1pmtons 
among the i,somers were noted for the second doublet, which according to 
the .re1sults presented ibeliow, can be ascribed to the C-terminal alanine methyl 
group. The signal of the i;-CH2 group of lysine residue was observable as a 
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TABLE II 
Chemical shifts of alanyl methyl protons in pentapeptides XVIII and XXII and 
related di- and tripeptides in D20 solutions as a function of pH
0 
Pep t d e 
I 
pH 
Chemical shift" . . c 
I I I H-Ala- -Ala- -Ala-OH Shift difference 
0.6 92.5 83.5 85.5 I 0 0 -5.5 H-Ala-Glu-Lys-Ala-Ala-OH 1.2 92.0 83.5 85.5 +0.5 0 -5.5 
5.6 92.5 83.5 80.0 0 0 0 
XVIII 9.0 79.0 83.0 79.0 + 13.5 + 0.5 + 1.0 
12.5d 74.5 82.5 79.0 + 18.0 + 1.0 + 1.0 
0.9 93.5 83.0 86.0 -1.0 -1.0 -6.5 
H-Ala-D-Glu 1.4 93.5 83.0 85.5 - ·LO -1.0 -6.0 
_i _ Lys-D-Ala-D .'..Ala-OH 4.5 92.5 82.0 80.5 0 0 --1.0 
6.8 92.5 82.0 79.5 0 0 0 
XXII 9.3 79.5 82.0 79.5 + 13.0 0 0 
12.1• 75.5 81.5 79.5 +17.o +o.5 0 
1.2 93.5 -1.0 
H-Ala-D-Glu-OH 4.0 92.5 0 
ll.5d 75.0 +17.5 
1.2 93.5 -0.5 
H-Ala-Glu-OH 3.8 93.0 0 
12.7• 75.5 +17.5 
0.9 85.0 86.0 -1.0 -6.5 
H-Lys-D-Ala-u-Ala-OH 7.8 84.0 79.5 0 0 
9.0 83.5 79.5 +o.5 0 
11.0 83.5 79.5 +o.5 0 
• Spectra were measured on solutions containing 20-30 mg of the peptide in D20. (0.5 ml) ; 
the pH of the solutions were adjusted with trifluoroacetic acid or NaOH + D20 and measured 
with a Radiometer pH meter 26. 
b Proton NMR spectra were determined on a Varian A-60A spectrometer at probe tempe-
rature. Chemical shifts (metyl doublets , J ~ 7 H z) are quoted in hertz downfield from internal 
sodium dimethylsilapentylsulphonic acid (SDSS) . H-Ala-, -Ala- and -Ala-OH represent alanyl 
residues at the N-terminal, central and C-terminal position, respectively. The error of measure-
ment was ± 1 Hz. 
c Up- ( + ) and downfield (-) shifts of the spectral lines of alanine methyl protons for 
acidic and basic solutions of the peptide relative to their position In solution containing the 
peptide. in .zwitterionic form. · 
• Chemical shift of CH quartet of N-terminal alanine : 212 Hz. 
broad .triplet: iin the spectra of isomers XVIII, XIX and XXII, which 
have the lysine i::-amin10 function unsubstituted, the signal appeared at a 
higher field as compared to i·ts position in the spectra of XX a1I1d XXI, whkh 
have the i::-amino group of lysine involved in the peptide bond. 
The assignement of the a.Ian~ne methyl resonances ·~n the a-a L-.pentaipeip-
tide XVIII and the y-a L-D-L-D-D-'pentaopeptide XXII was made .by using the 
Sheinblatt's method13 baised on the faot that the position of the spectral line of 
a gvoup adjacent t-0 a potentially ionizable group depends on the state 'Of 
ionisation of that group; accordingly, the resonance positions Qf the protons 
on the side chairrrs ·of amin'O acids are also influenced by the charged amino 
and carboxy-groups13-15. Hence, in both pentapeptide i-some11s, the addition of 
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base should shift the doublet of the N-terminal alanine methyl growp to 
higher field, acidification should shift the C-terminal alanine methyl signal 
toward lower field, whereas the signal of the penultimate alanine residue in 
the peptide chain should be affected only slightly by changes of pH. 
The shifts of the spectral lines of alanine methyl groups of XVIII and 
XXII and the related di- and tripeptides are given in Table II. The shifts 
observed for t;he two pentapeptides agree very well with those of the pairallely 
examined reference compounds, as well as with the data reported15 
for some related olilgopeptides. The assignement of the a-CH p.rotOIIl ·of N-
-terminal alanine was made by c01I1sidering the effects of pH changes ·on the 
proton resonances appearing in the region obscured by the large HOD peak: 
in basic solutilurus the one-1proton quartet was :str01I1gly shifted upfield rela.tive 
to i•ts porsitton .in the spectra of acidic and neutral soluti-ons of both pentapep-
tides as well as of the two reference dipeptides. In addition, a·t pH> 9, an 
upfield shift {- 25 Hz) of the lysine i:,-CH2 triplet, due to neutralization of 
the i:,-NH / group was clearly observable. On the other hand, resolu·tion and 
assignements of the u -CH protons to particu1'ar amiino acids i:n the pentapeptide 
molecules were il'lJOt possible with the magnet used. 
Hence, the chemical shift differences •of alran1ne methyl doubJets are 
large enough to permiit assignement of the three alanine ·restdues im the 1so-
meric pen1apeptides XVIII and XXII by the above simple l'fMR procedure. 
The resu!Jts suggest that this procedure may .be also u1seful ·in structure eluci-
dation of similar peptides isolated from natural material. 
EXPERIMENTAL 
General 
Melting poiJnts are uncorrected. Organic solutions were dried 'OV'er anhydrous 
sodium sulphate, 81Ild concentrations were ca11ried out under reduced pressure dm 
a rotary evaporator at minimum temperature. TLC was conducted on .plates coated 
with Kiesel G (Merck), and paper-chromatography and -electrophocesis were per-
formed on Whatman No 1 paper. The homogeneity of the intermediates and end 
products was ascertained by TLC or paper-chromatography iJn following solvent 
systems (v/v): A, chloroform-methanol (1 : 1); B, ethyl acetate-benzene (1 : 1); C, 
chloroform-acetone (3 : 2); D, n-butanol-pyirid:ilne-acetic acid-water (15 : 10 : 3 : 12); 
E, iso-butyric acid-cone. ammonia-water (66: 2: 23); F, n-butanol-acetic acid-water 
(60 : 15 : 25). Compounds with free amino groups were detected w.i.th ninhydrin, 
N-acylated compoumds were revealed either by ninhyddn, after sprayiJng the plates 
with 20/o HBr in acetic acid-ethanol (1 : 5) and heating, or by the chlorine-.starch-
-iodine method. 
Optical .rotatiOIIls were determined for 1 O/o solutiOIIlS, if not stated otherwise, at 
20-25 °c in the solvent specified. Proton NMR spectra were recorded on a Va~·ian 
A-60A .spectrometer in deuterochloroform and deuteromethainol with tetramethyl-
silane (TMS) as internal standard, and in deuterium oxide by using sodium dimethyl-
silapenty1sulphonic acid (SDSS) as inte.rnal standard, if not \Stated otherwise. 
N-tert-ButoxycarbonyL-L-alanyL-5-benzyl-L-glutamic Acid (I) 
(DicycLohexyLammonium Salt) 
To a stirred suspension of 5-bernzyl-L-glutamic acid (3.92 g, 16.6 mmoles) and 
sodium hydrogen carbonate (1.39 g, 16.6 mmoles) iJIIl water (25 ml), N-tert-butoxy-
carbonyl-L-alarnne N-hydroxyisuccinimide ester (2.86 g, 10 mmoles) .in 1,2-dimethoxy-
ethane (25 ml) was added at room temperature; after 3 hr of stirriJIIlg, the mixture was 
acidified at 0 °c with aqueous 100/o citric acid to pH 3. The precipitated 5-benzyl-L-
-glutamic acid was filtered off, the filtrate was concentrated to about one third · 
of the volume, and the product was extracted with ethyl acetate (3 x). The combined 
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organic layers were washed with water, dried and concentrated. The remammg 
oil was dissolved in ethyl acetate (10 ml) and dicyclohexylarlline (1.80 g, 10 mmoles) 
in ethyl acetate (5 ml) was added under stirrrng; subsequent addition of petroleum 
ether at 0 °c precipitated the DCHA salt of I (5 .6 g, 95%), m . p. 135-137 °c. After 
crystalliza.tion from ethyl acetate~petroleum ether, the product had m . p. 139-141 °c 
and [a] 0 + 1.6° (c 2, DMF). 
Anal. Cs2H51Na07 (589.75) calc'd.: C 65.17; H 8.72; N 7.13°/o 
found: C 65.45; H 8.90; N 7.04()/o 
A sample of the above salt was dissolved in precooled aqueous 25°/o citr.ic acid 
(5 ·ml), the solution was extracted with ethyl acetate (3 x), and rthe combim.ed extracts 
were washed with water, dried and conceintrated. The remaining oil was dissolved 
in dry ether (5 ml); subsequent addition of petroleum ether at o° C precipitated the 
dipeptide I as colourless crystals, m. p. 75--77 °c, [a.] 0 - 7.6 ° (c 1.7, DMF). NMR 
data (CDCls) : r 0.11 (s, 1 H, COOH), 2.73 (s, 5 H, Ph), 2.88 (d, 1 H, J = 8 Hz, NH), 
4.92 (s, 2 H, PhCH20), 8.62 (s, 9 H, Me~C), 8.68 (d, J = 7 Hz, the downfield peak 
masked by Me3C signal,. Me-CH). 
Anal. C2oH2sN20 7 (408.44) calc'd. : C 58.81; H 6.91; N 6.86°/o 
found: C 58.58; H 7.10 ; N 6.650/o 
N-tert-Butoxycarbonyl-L-alanyl-5-benzyl-L-glutamic Acid 
N-Hydroxysuccinimide Ester (II) 
The DCHA salt of I (1.47 g, 2.5 mmoles) was treated with citr,ic acid as descl'ibed 
above, and to the free peptide in erthyl acetate (5 ml) . were added N-hydroxy-
succinimide (288 mg, 2.5 mmoles) and dicyclohexylcarbodi-imide (DCC, 516 mg, 2.5 
mmoles) in erthyl acetate at 0 °C. The mixture was kept at 0 °c for 24 hr whereupon 
N,N'-dicyclohexylUJrea was filtered off, arnd the filtrate wa•s washed w~th 100/o citric 
acid, water, saturated aqueous sodium hydrogen carbonate and water, dried and 
concentrated. The remaining viscous oil (1.2 g, 950/u) traveled as a siJngle spot on 
TLC iJn solvents A and C; [alu - 21.0 o (EtOAc). NMR data (CDC13): r 2.71 (s, 5 H , 
Ph), 2.88 (d, 1 H, J = 8 Hz, NH), 4.91 (s, 2 H, PhCH20), 5.79 (q, 1 H , CH of Ala), 
7.23 (s, 4 H, 2 X CH2 from succirnimide), 8.61 (s, Me3C), 8.68 (d, 3 H, J = 7 Hz, the 
downfield peak masked by Me3C s.ignal, Me-CH). 
Anal. C24Ha1Na09 (505.51) calc'd.: C 57.02; H 6.18; N 8.310/o 
found : C 57.25; H 6.40; N 8.380/o 
N-tert-Butoxycarbonyl-L-alanyl-1-benzyl-L-glutamic Acid (III) 
(Dicyclohexylammonium Salt) 
Starting with 1-benzyl L-glutamic acid (1.77 g), the procedure described for 
the preparation of the isomeric dipeptide I was followed to give the JJCHA salt of 
III : 3.55 g, 81.00/o, m . p. 157-159 °c, [a] 0 -16.0° (EtOH), [a] 0 -16.8° (DMF) . 
Anal. C32H 51N30 7 (589.75) calc'd.: C 65.17; H 8.72; N 7.130/o 
found: C 64.89; H 8.98; N 7.000/o 
A sample of the aibove salt was treated with aqueous citric acid as described for 
I to give the free dipeptide III as a chromatographically homogeneous oil which 
crystallized subsequently from ether-petroleum ether at 0 °C: m. p 43-49 °C, [aj 0 
- 22.4 ° (DMF). 
Anal. C20H2sN201 (408.44) calc'd.: C 58.81; H 6.91; N 6.86P/o 
found: C 58.96; H 6.87; N 6.690/o 
N-tert-Butoxycarbonyl-L-alanyl-1-benzyl-L-glutamic Acid 
N-Hydroxysuccinimide Ester (IV) 
To a solution of III (prepared from 3.54 g of III X DCHA salt as described 
above) in ethyl acetate (15 ml) were added N-hydroxysucoinimide (690 mg) and DCC 
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(1.24 g) in ethyl acetate at 0 °c, and the mixture was further treated as described 
for II. After worik up, the active ester IV was obtained as a viscous oil which 
crystallized subsequently from chloroform-petroleum ether at O oc: m. p. 96--98 oc, 
[o.] 0 -11.7° (EtOAc), yield: 700/o. NMR data (CDC13): -r: 2.74 (s, Ph), 2.97 (d, 1 H , 
J = 8 Hz, NH), 4.68 (d, 1 H , J = 8 Hz, NH), 4.87 (s, 2 H, PhCH20), 5.91 (q, 1 H , CH 
of Ala) , 7.25 (s, 4 H, 2 X CH2 from sucainimide), 8.61 (s, Me3C), 8.70 (d, 3 H, J= 7 Hz, 
Me-CH). 
Anal. C24H81N309 (505.51) calc'd.: C 57.02; H 6.18; N 8.310/o 
found: C 57.01; H 6.18; N 8.38°/o 
N-tert-Butoxycarbonyl-L-alanyl-1-benzyl-n-glutamic Acid (V) 
The DCHA salt of V7 was prepared as described for III aind then treated with 
aqueous citric acid to give the free di.peptide V as a viscous oil which crystallized 
from ether-petroleum ether: m.p. 88-89 °c, [o.] 0 + 9.3° (DMF). Lit.16 : m.'p. 83-84 °c, 
[a] 0 + 18.34° (DMF). NMR data (CDC13): -r: 0.94 (broad, 1 H, COOH), 2.71 {s, Ph), 2.99 
(d, J = 8 Hz, NH), 4.87 (s, 2 H, PhCH20), 8.60 (s , Me3C), 8.67 (d , J = 7 Hz, the down-
field peak maske d by Me3C, Me-CH). 
Anal. C20H2sN20 7 (408.44) aalc'd.: C 58.81; H 6.91; N 6.860/o 
found: C 59.04; H 7.08; N 6.720/o 
N-tert-Butoxycarbonyl-L-alanyl-1-benzyl-n-glutamic Acid 
N-Hydroxysuccinimide Ester (VI) 
Starting with V (1.74 g), the procedure described for the preparati001 of the 
diastereoisomeride IV was used. After work up, the active ester VI was •obtained as 
a solid foam (1.94 g). A sample was crystallized from ethyl acetate-petroleum ether: 
on standLng at O 0c, crystals with m . p. 84-86 °c and [o.] 0 - 7 .0° (c 0.6, EtOAc) depo-
sited. ·NMR data (CDC13): -r: 2.70 (s, Ph), 3.03 (d, 1 H, J = 8 Hz, NH), 4.85 (s, 2 H, 
PhCH20), 5.87 (q, 1 H, CH of Ala), 7.21 (s, 4 H , 2 x CH2 from succi.nimide), 8.58 (s, 
Me3C), 8.68 (d, 3 H, J = 7 Hz, Me-CH). 
Anal. C24H31N309 (505.51) calc'd.: C 57.02; H 6.18; N 8.310/o 
found: C 57.13; H 6.46; N 8.120/o 
N 2-tert-Butoxycarbonyl-N6-benzyloxycarbonyl-L-lysyl-L-alanyl-
-r.-alanine Benzyl Ester (VII) 
To N-tert-butoxycarbonyl-L-alanyl-L-alanine benzyl ester17 (1.75 g, 5 mmoles) 
was added cold trifluo.roacetic acid (8 ml), and the solution was keipt at 0 °c fo.r 
30 min and then at ambient temperature for 15 min. Trifluoroacetic acid was 
evaporated and traces were removed by repeated co-distillation with benzene; the 
residue was dissolved in DMF (4 ml) and neutralized with N-methy1morpholillle 
(0.56 ml) at O 0c. To this solution were added under stirring at 0 °c N2-tert-butoxy-
carb001yl-N6~benzyLoxycarbOlllyl-L-lysine p-nitrophenyl ester5 (2.5 g, 5 mmoles) and 
imidazole (680 mg, 10 mmoles) in DMF (5 ml each). The reaction mixture was kept 
at 0 °c for 24 hr, whereupon it was diluted with water and extracted with ethyl acetate 
(3 x 50 ml). The combined extracts were washed with 100/o aqueous citric acid, water, 
saturated aqueous sodium hydrogen carbonate and water, dried and concentrated. 
The residue was crystallized from hot ethanol to -give the fully protected tripeptide 
VII (2.2 g, 720/o) , m. p. 132-134 °c. A second crystallization from ethyl acetate-pe-
troleum ether afforded the analytical sample. m. p. 134-136 °c, [o.] 0 - 17.90 (DMF). 
Anal. Ca2H44N40s (612.70) calc'd.: C 62.72; H 7.24; N 9.150/o 
found: C 62.48; H 7.45; N 9.260/o 
N 6-Benzyloxycarbonyl-L-lysyl-r.-al.anine Benzyl Ester (VIII) 
(Trifluoroacetate Salt) 
The foregoilng peptide VII (766 mg, 1.25 mmole) was treated with trifluoroacetic 
acid (5 ml) as described above, and the residue was dissolved Ln ethyl acetate; sub-
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sequent addition of ether a·t 0 °c precipitated the trifluoroacetate salt of VIII (640 mg, 
81.8-0/o), m. p. 165-166 °c, [aln-8.0° (DMF). 
Anal. C29Ha1FaN40a (626.62) calc'd.: C 55.58; H 5.95; N 8.940/o 
found: C 55.59; H 6.20; N 8.940/o 
N 2-Benzyloxycarbonyl-N6-tert-butoxycarbonyl-L-lysyl-L-alanyl-
-L-alanine Benzyl Ester (IX) 
To a solution of L- alanyl-L-ala:nine benzyl ester in DMF (2 ml), prepared from 
BOC-Ala-Ala-OBZL (525 mg, 1.25 mmole) as described in the preparation of VII, 
were added under stirring at 0 °c N2-benzyloxycarbonyl-N6-tert-butoxycarbonyl-L-
-lysine N-hydroxysuccinimi<le ester18 (717 mg, 1.5 mmole) and imidazole (204 mg, 
3 mmoles) in DMF (3 ml each). The reaction mixture was further treated as de-
scribed for the synthesis of VII; crystallization of the product from ethyl acetate-
-petroleum ether, followed by ethanol, afforded the analytical .sample of the tri-
peptide IX (yield 700 mg, ,760/o), m. p. 132-133 °C, [anl -19.1° (DMF) . 
Anal. Ca2H 44N40 a (612.70) calc'd .: C 62.72; H 7.24; N 9.150/o 
found: C 62.62; H 7.28 ; N 9.400/o 
N 2-Benzyloxycarbonyl-L-lysyl-L-alanyl- L-alanine Benzyl Ester 
(X) (Trifluoroacetate Salt) 
The foregoing tripept1de IX (140 mg, 0.23 mmole) was treated with trifluoroacetic 
acid as described above; after crystallization from ethyl acetate-petroleum ether, the 
trifluoroacetate salt of X (116 mg, 810/o) had m . p. 114-116 °c and [aln - 21.0° (c 0.5, 
DMF). 
Anal. C29Ha1FaN40s (626.62) calc'd.: C 55.58 ; H 5.95; N 8.940/o 
found: C 55.76 ; H 6.22; N 8.830/o 
N 2-tert-Butoxycarbonyl-N6-benzyloxycarbonyl-L-lysyl-n-alanyl-D-alanine 
Benzyl Ester {XI) 
Starting with N-tert-butoxycarbonyl-n-alanyl-n-alanine benzyl e ster19 (2.45 g, 
7.0 mmoles), the procedure described for the synthesis of VII was used. Crystallization 
from ethanol gave the L-D-D-tripeptide XI (3.3 g, 77.00/o), m. p. 120--122 °c; the 
analytical sample had 122-124 °c (from ethyl acetate-petroleum ether) and [a] 0 + 
+ 9.4° (DMF), [a]D + 32.7° (MeOH). Lit.9 : m . p. 118-120 °c, [a]D + 30.3° (c 0.7, MeOH); 
lit.10 : m.p. 110-112°C, [a] 0 + 32.1° (c 1.4, MeOH). NMR data (CDC13): r 2.73 (s, 10 H, 
2 X Ph), 4.88 (s, 2 H, PhCH20), 4.95 (s, 2 H, PhCH20CON), 8.61 (s, Me3C), 8.62 and 
8.66 (2 d, J = 7 Hz, the downfield peaks masked by Me3C signal, 2 x Me-CH). 
Anal. C32H 44N408 (612.70) calc'd.: C 62.72; H 7.24; N 9.150/o 
found : C 62.58 ; H 7.37; N 9.020/o 
N6-Benzyloxycarbonyl-L-lysyl-n-alanyl-n-alanine Benzyl Ester (XII) 
(Trifluoroacetate Salt) 
The foregoing tripeptide XI (1.3 g, 2.12 mmoles) was treated with trifluoroacetic 
acid (4 ml) as descrtbed above to give the trifluoroacetate salt of XII (1.2 g, 900/o); 
the analytical sample had m . p. 145-147 °c (ethyl acetate-ether) aind [aln + 31.0° 
(DMF). 
Anal. C29H31F3N408 (626.62) calc'd. : C 55.58; H 5.95; N 8.940/o 
found: C 55.60; H 6.16 ; N 8.940/o 
To a sample (120 mg) of the above salt in methanol (0.5 ml) was added .at 0 °c 
1 equivalent of triethylamine in ethyl acetate (15 ml); the mixture was stirred for 
15 min, the organic phase was washed with water, dried and evaporated, and the 
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residue was dissolved in methanol-d4. NMR data (CDaOD): r 2.75 (s, 10 H, 2 X Ph), 
4.90 (s, 2 H, PhCH20), 4.96 (s, 2 H, PhCH20CON), 8.61 and 8.70 (2 sets of overlapping 
doublets, 2 X 3 H, J = 7 Hz, 2 X Me-CH). 
N-·tert-Butoxycarbonyl-L-alanyl-5-benzyl-L-glutamyl-N6-benzyloxycarbonyl-L-
-lysyl-L-alanyl-L-alanine Benzyl Ester (XIII) 
To a solution of the trifluoroacetate salt o·f VIII (576 mg, 0.92 mmole) in DMF 
(5 ml) was added N-methylmorpholine (0.1 ml, 0.92 mmole) at o0c. The mixture was 
stirred for 10 min, the dipeptide active ester II (465 mg, 0.92 mmole) in DMF was 
added, and stLrriing was continued for 1 hr at O 0c. The reaction mixture was kept at 
O 0c for 48 hr whereupon it was diluted with water (15 ml), ·the precipitated prnduct 
was filtered off, wa1shed with water and ether-petroleum ether (1 : 1) and dried. 
Cryisfallization from ethyl acetate-petroleum ether gave the protected pentapeptide 
XIII (717 mg, 860/o), m. p. 161-162 °C. A second crystallisation fcrom ethanol afforded 
the analytical sample, m. p. 162-163 °C, [a] 0 - 19.8° (DMF). NMR data (CDC13): r 2.72, 
2.80, 2.83 (3 s, 15 H, 3 X Ph), 4.84 .(s, 2 H, PhCH20 of Ala), 5.03 (s, 4 H, 5-PhCH20 of 
Glu + PhCH20CON of Lys), 8.64 (s, Me3C); (CD30D): r 2.70 (s, 15 H, 3 X Ph), 4.88, 
4.91, 4.96 (3 X 2 H singlet~, PhCH20 pf Ala, 5-PhCH20 of Glu, PhCH20CON), 8.60 {s, 
MeaC), 8.64 (d, the downf1eLd peak masked by Me3C, Me-CH), 8.69 and 8.73 (2 sets of 
overlapping doublets, 2 x 3 H, J = 7 Hz, 2 x Me-CH). 
Anal. C41H52N5012 (903.02) calc'd.: C 62.51; H 6.92; N 9.31°/o 
found: C 62.47; N 6.95; N 9.170/o 
N-tert-Butoxycarbonyl-L-alanyl-1-benzyl-L-y-glutamyl-N6-benzyloxycarbonyl-L-
-lysyl-L-alanyl-L-alanine Benzyl Ester (XIV) 
The tdpeptide VIII was Liberated from its trifluoroacetate salt (1.25 g, 2 mmoles) 
as described above, and coupled with the dipeptide active ester IV (1.01 g, 2 mmoles) 
by the 1same procedure which is descri1ted for the synthesis of XIII. Crystallization 
of the precipitated p•11oduct from ethanol gave XIV (1.2 g, 66.50/o), m. p. 161-163 °C; 
two further crystallization from DMF-petroleum ether and then from ethanol gave 
the analytical sample, m. p. 179-181 °c (siintering at 165 °C), [a]D - 17.9° (DMF) . NMR 
data (CDC13):r 2.72 (s, 3 Ph), 4.88 (s, 4 H, PhCH20 of Ala+ l-PhCH20 of Glu), 4.95 
(s, 2 H, PhCH20CON), 8.60 (s, Me3C), 8.68 and 8.70 (overlapping doublets 1partly masked 
by Me3C, 3 X Me-CH); {CD30D): r 2.72 (s, 3 PH), 4.89 (s, 4 H, PhCH20 of Ala+ 
+- 1-PhCH20 of Glu), 4.95 (s, 2 H, PhCH20CON), 8.60 (s, Me3C), 8.66 (d, 3 H, J = 7 Hz, 
partly masked by Me3C, Me-CH), 8.70 and 8.76 (2 sets of overlapping doublets, 2 X 3 H, 
J = 7 Hz, 2 X Me-CH). 
Anal. C47H52N5012 (903.02) calc'd.: C 62.51; H 6.92; N 9.31% 
found: C 62.66; H 7.17; N 9.53°/o 
N2-Benzyloxycarbonyl-N6-[N-tert-butoxycarbonyl-L-alanyl-5-benzyl-L-
-glutamyl]-L-lysyl-L-alanyl-L-alanine Benzyl Ester (XV) 
The trifluoroacetate salt of X (1.25 g, 2 mmoles) was liberated from its salt and 
the tripeptide X was coupled with II as described for the isomeric pentapeptide 
XIII. Crystallization from ethanol gave XV (926 mg, 51.30/o); the analytical sample 
had m. p. 156-158 °c (ethyl acetate-petroleum ether) and [a]D - 22.0° (DMF). NMR data 
(CDC13): r 2.71 (s, 3 Ph), 4.87 (s, 2 H, PhCH20 of Ala), 4.92 (s, 4 H, .5-PhCH20 of 
Glu + PhCH20CON), 8.59 (s, Me3C); (CD30D): r 2.71 (s, 3 Ph), 4.88, 4.91, 4.93 '(3 X 
X 2 H singlets, PhCH20 of Ala, 5-PhCH20 of Glu, PhCH20CON), 8.60 (s, Me3C}, 8.69 
and 8.74 (2 sets of overlapping doublets, 3 H + 6 H, J = 7 Hz, partly masked by MeaC, 
3 X Me-CH). 
Anal. C41H62N60 12 (903.02) calc'd.: C 62.51; H 6.92; N 9.310/o 
found: C 62.31 ; H 7.00; N 9.330/o 
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N 2-Benzy loxycarbony l-N6-[N-tert-butoxycarbony l-L-alany l-1-b enzy l-L-y-
-g lutam y l]-L-l ysy l-L-alanine Benzyl Ester {XVI) 
Starting with the trifluoroacetate salt of X (602 mg, 0.96 mmole) and the di-
peptide active ester IV (486 mg, 0.96 mmole), the procedure described for the pre-
paration of XIII was used. Crystallization of the precipitated product from a minimal 
amount of ethanol gave the pentapeptide XVI (430 mg, 500/o), and a second crystal-
lization from the same solvent afforded the analytical sample: m. p. 175-177 oc 
(siintering at 158 °C), [a] 0 -13.3° (DMF). NMR data (CDC13): -r 2.72 (s, 3 Ph), 4.87 
(s, 4 H, PhCH20 o.f Ala + l-PhCH20 of Glu), 4.96 (s, 2 H, PhCH20CON), 8.60 (s, 
Me3C); (CD30D): -r 2.71 (s, 3 Ph), 4.88 (s, 4 H, PhCH20 of Ala+ 1-PhCH20 of Glu), 
4.97 (s, 2 H, PhCH20CON), 8.59 (s, Me3C) , 8.70 and 8.75 (2 sets of overlapping doublets, 
3H + 6 H, J = 7 Hz, partly masked by Me3C, 3 X Me-CH) . 
Anal. C41H62N60 12 (903.02) calc'd.: C 62.51; H 6.92; N 9.310/o 
found: C 62.43; H 6.65; N 9.48°/o 
N-te,rt-Bu toxyca r bony l-r:-a la n y l-1-b enzy I-n-y-g l u tam y l-N 6- b enzy loxyca r bony l-
-L-l y sy l-n-ala n y l-n-a la nine Benzyl Ester (XVII) 
Starting with the L-D-n-tripeptide XII (931 mg, 1.49 mmole) trif1uoroacetate salt 
and the L-n-dipeptide active ester VI, the procedure described for the preparation 
of XIII was used. The crude pentapeptide XVII (1.14 g, 850/o) had m. p. 154-155 °c 
and [a] 0 + 20.1° (MeOH); two recrystallization from ethanol afforded the analytical 
sample, m.p. 160~162 °c, [a] 0 + 21.6° (MeOH), [a)D + 12.3° (DMF). Lit.
10 : m. p. 
154-156 °C, [a] 0 + 18.1° (MeOH) . NMR data (CDC13): -r 2.72 (s,. 3 Ph), 4.88 (broad singlet, 
4 H, 2 x PhCH20) and 4.94 (s, 2 H, PhCH20CON), 8.61 (s, Me3C); (CD30D): -r 2.73 (s, 
3 Ph), 4.90 (broad singlet, 4 H , 2 X PhCH20), 4.97 (s, 2 H , PhCH20CON), 8.59 (s, Me3C), 
8.62 (d, .partly masked by Me3C, Me-CH), 8.69 and 8.74 (2 1sets of overlapping doublets, 
J = 7 Hz, 2 X Me-CH). 
Anal. C41H62N6012 (903.D2) calc'd.: C 62.51; H 6.92; N 9.31% 
found: C 62.31; H 6.96; N 9.480/o 
Removal of the Protecting Groups of Pentapeptide Isomers XIII-XVII 
General Procedure. - To a solution of the protected pentapeptide (476 mg, 0.5 
mmole) in acetic acid (5 ml) , was adedd 1001~ Pd/C (Fluka puriss., 100 mg), and the 
mixture was shaken at room temperature and pressure until the uptake of hydrogen 
was complete (- 10 hr, monitoring by TLC iJn solvent 1systems D and E). The catalyst 
was centrifuged off, washed with acetic acid, and the combined superinatants were 
evaporated to dry1J1ess (0.1 Torr, bath 30 °C). The residue was dissolved at O 0c in 
trifluoroacetic acid (4 ml); after 20 m.iin at 0 °C and 10 min at ambient temperature, 
dry ether was added to the solution, and the precipiJtate was centrifuged off, washed 
with dry ether (3 X) and dried. A second crystallization from trifluoroacetic acid-dry 
ether, followed by drying in vacuo over phosphorous pentoxyde and cone. sulphuric 
acid, afforded the analytical sample. 
Pentapeptides XVIII-XXII di-trifluoroacetate salts were subjected in parallel 
runs to paper chromatography in solvent systems cited below. NMR .spectra of 
XVIII-XXII di-TFA salts were taken in D20 with TMS as extern.al standard. 
Alaniine methyl groups invariably produced doublets with J = 7 Hz; in all spectra_ 
2 doublets were observed as 3 peaks. 
r,-Alanyl-L-glutamyl-L-lysyl-L-alanyl-L-alanine (XVIII) 
(Di-Trifluoroacetate Salt) 
Yield: 860/o, m. p. 145-150 °c (decomp.), [a] 0 - 47.4° (c 1.39, water). R f (solvent 
system): 0.17 (D); 0.65 (E); 0.13 (F). NMR data: -r 8.47 and 8.59 (2 d, 2 X 3 H, 2 X 
X Me-CH), 8.62 (d, 3 H, Me-CH), 7.00 (broad, t, 2 H, c-CH2 of Ly1s). 
Anal. C24HasF6N6012 (716.59) calc'd: C 40.22; H 5.35; N 11.730/o 





Yie1d: 83%, m.p. 115-120 °c (decomp.), [a] 0 -36.7° (c 0.79, water) . Rf: 0.15 (D); 
0.56 (E); 0.09 (F). NMR data: r 8.46 and 8.57 (2 d, 2 X 3 H, 2 X Me-CH), 8.61 (d, 
3 H, Me-CH), 6.98 (broad, t, .s-CH2 of Lys). 
Anal. C24HasF6N6012 found: C 40.33; .H 5.63; N 11.55°/o 
N 6[-L-Alanyl-L-glutamyl]-L- l ysyl-L-alany l -L- a lanine (XX) 
(Di-Trifluoroacetate Salt) 
Yield: 76°/o, m. p. 110_:._115 °c (decomp.) , [a] 0 -19.8° (c 1.5, water). Rf: 0.19 
(D); 0.66 (E); 0.11 (F). NMR data: r 8.49 and 8.61 (2d, 2 X 3 H, 2 X Me-CH), 8.59 
(d, 3 H, Me-CH), 6.80 0broad, t, 2 H s-CH2 of .Lys). 
Anal. C24H3sF6N6012 fo~nd: C 40.37; H 5.33; N 11.70'°/o 
N6-[L- Alan y l-L-y-g lutamy l ]-L-lysy l- r.-alan y l-L-ala nine (XXI) 
(Di-Trifluoroacetate Salt) 
Yield: 800/o, m. p. 125-130 °C (decomp.), [a] 0 - 15.1° (water). Rf: 0.16 (D); 0.58 
(E); 0.11 (F). NMR data: r 8.49, and 8.61 (2 d, 2 X 3 H, 2 X Me-CH), 8.63 (d, 3 H , 
Me-CH), 6.85 (broad, t, 2 H, .s-CH2 of Lys). 
Anal. C24HasF6N6012 found: C 40.04 ; H 5.48; N 11.840/o 
L-Alanyl-n-y-glutamyl-L-lysyl-n-alanyl-n-a1.anine (XXII) (Di-Trifluoroacetate 
Salt) 
Yield : 85'0/o, m.p. 125-130 °c (decomp.), [a] 0 + 17.5° (water). Rf: 0.14 (D); 0.49 
(E); 0.10 (F). NMR data: T 8.44 and 8.57 (2d, 2 X 3 H, 2 X Me-CH), 8.62 (d, 3 H , 
Me-CH), 6.93 (broad, t, 2 H, s--CH2 of Lys) . 
Anal. C24H38F 6N60 12 found: C 40.29; H 5.37; N 11.890/o 
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SAZETAK 
Cetiri strukturna izomera L-pentapeptida sekvence Ala. Glu. Lys. Ala. Ala. Sinteza, 
karakterizacija i korelacija Sa izomerom L-D-L-D-D-konfiguracije cija struktura je 
srodna peptidskim lancima peptidoglikana 
D. Goles, L. Tomic i D. Keglevic 
Opisana je silnteza cetiri L-pentapeptida sekvence Ala . Glu. Lys. Ala. Ala. koji 
se medusobno razlikuju obzirom na mjesto peptidske veze izmedu glutamil i lizil 
ostatka. U svim slucajevima peptidski lanac je dobiven kondenzacijom potpuno 
protektiranog dLpeptid sukcinimid estera (BOC-Ala-Glu(OBZL)-OSu ili BOC-Ala-
-Glu(OSu)-OBZL), kao N-termi.nalne kompo.neUJte, sa protektiranim tripeptid b~zil 
esterom (Lys(Z)-Ala-Ala-OBZL ili Z-Lys-Ala-Ala-OBZL), kao C-terminalnom kom-
ponentom. Po tstoj shemi si.ntetiziran je i odgovarajuCi pentapeptid L-D-L-D-D-kon-
figuracije u kojem je y- karboksil grupa n-glutamil ostatka vezana sa u_;amino 
grupom L-lizil ostatka. Deprotekcija izomern.ih pentapeptida izvrsena je u dva 
stupnja: 1. katalitickim hidriranjem, i 2. djelovanjem trifluoroctene kiselilne. Slobodni 
pentapeptidi izoli.rani su kao di-trifluoracetat soli i karakterizirani analizom, opti-
ckim skretanjem i NMR spektrima. Korelirana je elektroforetska pokretljivost izo-
mera kod razlicitih pH vrijed!llosti. Primjenom NMR titracije provedena je asignacija 
alanhiskih ostataka u peptidskom lancu a-a L-izomera XVIII i y--a. L-D-L-D-D-
-izomera XXII. 
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